Literature DB >> 17174341

Mechanisms by which acyclovir reduces the oxidative neurotoxicity and biosynthesis of quinolinic acid.

Adrienne C Müller1, Amichand Dairam, Janice L Limson, Santy Daya.   

Abstract

The concentration of the endogenous neurotoxin quinolinic acid (QA) is increased in the central nervous system of mice with herpes simplex encephalitis. We have previously shown that the antiherpetic agent acyclovir (AC) has the ability to reduce QA-induced neuronal damage in rat brain, by attenuating lipid peroxidation. The mechanism by which QA induces lipid peroxidation includes the enhancement of the iron (Fe)-mediated Fenton reaction and the generation of free radicals, such as the superoxide anion (O(2)(-)). Thus, the present study determined whether AC has the ability to reduce Fe(2+)-induced lipid peroxidation, O(2)(-) generation and QA-induced superoxide anion generation, and to bind free Fe. O(2)(-) and Fe(2+) are also cofactors of the enzymes, indoleamine-2,3-dioxygenase (IDO) and 3-hydroxyanthranilate-3,4-dioxygenase (3-HAO) respectively. These enzymes catalyse steps in the biosynthesis of QA; thus, the effect of AC on their activity was also investigated. AC significantly attenuates Fe(2+)-induced lipid peroxidation and O(2)(-) generation. AC reduces O(2)(-) generation in the presence of QA and strongly binds Fe(2+) and Fe(3+). It also reduces the activity of both IDO and 3-HAO, which could be attributed to the superoxide anion scavenging and iron binding properties, respectively, of this drug.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17174341     DOI: 10.1016/j.lfs.2006.11.031

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

Review 1.  Microenvironmental clues for glioma immunotherapy.

Authors:  Michael Platten; Katharina Ochs; Dieter Lemke; Christiane Opitz; Wolfgang Wick
Journal:  Curr Neurol Neurosci Rep       Date:  2014-04       Impact factor: 5.081

2.  Acyclovir inhibits rat liver tryptophan-2,3-dioxygenase and induces a concomitant rise in brain serotonin and 5-hydroxyindole acetic acid levels.

Authors:  Adrienne C Müller; Santy Daya
Journal:  Metab Brain Dis       Date:  2008-07-30       Impact factor: 3.584

Review 3.  Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease.

Authors:  Robert Schwarcz; Paolo Guidetti; Korrapati V Sathyasaikumar; Paul J Muchowski
Journal:  Prog Neurobiol       Date:  2009-04-24       Impact factor: 11.685

4.  Acyclovir inhibition of IDO to decrease Tregs as a glioblastoma treatment adjunct.

Authors:  Johan Söderlund; Sophie Erhardt; Richard E Kast
Journal:  J Neuroinflammation       Date:  2010-08-06       Impact factor: 8.322

Review 5.  Quinolinic acid: an endogenous neurotoxin with multiple targets.

Authors:  Rafael Lugo-Huitrón; Perla Ugalde Muñiz; Benjamin Pineda; José Pedraza-Chaverrí; Camilo Ríos; Verónica Pérez-de la Cruz
Journal:  Oxid Med Cell Longev       Date:  2013-09-05       Impact factor: 6.543

6.  Quinolinic acid: neurotoxin or oxidative stress modulator?

Authors:  Lenka Kubicova; Franz Hadacek; Vladimir Chobot
Journal:  Int J Mol Sci       Date:  2013-10-25       Impact factor: 5.923

7.  Sustained elevation of kynurenic Acid in the cerebrospinal fluid of patients with herpes simplex virus type 1 encephalitis.

Authors:  Ann Atlas; Elisabeth Franzen-Röhl; Johan Söderlund; Erik G Jönsson; Martin Samuelsson; Lilly Schwieler; Birgit Sköldenberg; Göran Engberg
Journal:  Int J Tryptophan Res       Date:  2013-11-25

Review 8.  Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis.

Authors:  Michael D Lovelace; Bianca Varney; Gayathri Sundaram; Nunzio F Franco; Mei Li Ng; Saparna Pai; Chai K Lim; Gilles J Guillemin; Bruce J Brew
Journal:  Front Immunol       Date:  2016-08-04       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.